This public procurement record has 3 releases in its history.

Award

18 Dec 2024 at 14:37

Tender

04 Jul 2024 at 18:06

Planning

24 May 2024 at 09:11

Summary of the contracting process

The NHS England has completed a public procurement process titled "NHS National Generic Pharmaceuticals Wave 15a," focusing on pharmaceutical products under the industry category of goods. This procurement is linked to a framework agreement with a potential maximum duration of 48 months, starting on 1st February 2025. The procurement covered several regions across the UK, including CESW, LSNE, NWLN, DNW, DLN, DLS, DNE, DCE, and DSW. The initial agreement period varied across lots, with the longest duration being 28 months. The open procedure procurement method was used for the tender, and it was completed with final contracts signed on 5th November 2024. The tender had multiple lots, including oral products for all regions and hospital-only products for specific regions.

This tender provides substantial opportunities for businesses in the pharmaceutical sector, especially those supplying generic medications. The framework agreement's significant duration and potential for extensions mean stable and ongoing business prospects. The tender's division into lots allows for both large and smaller suppliers, including SMEs, to compete, fostering a diverse supplier base and encouraging new market entrants. Companies with strengths in producing or distributing hospital-specific and oral pharmaceutical products would greatly benefit from participating in such contracts, given the high demand and widespread regional requirements. This procurement initiative can help businesses establish long-term relationships with NHS England and other participating bodies, enhancing their profiles and market share in the healthcare sector.

How relevant is this notice?

Notice Title

NHS National Generic Pharmaceuticals Wave 15a

Notice Description

NHS National Generic Pharmaceuticals - Wave 15a.<br/>Offer reference number: CM/PHG/23/5697.<br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.<br/><br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/PHG/23/5697/01 - Orals (plus non-parenteral) Products:<br/>All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months)<br/><br/>CM/PHG/23/5697/02 - Hospital Only Products:<br/>DNW & DLN: 01/02/2025 to 31/01/2027 (24 months)<br/><br/>CM/PHG/23/5697/03 - Hospital Only Products (Housekeeping):<br/>DLS & DNE: 01/02/2025 to 31/05/2026 (16 months)<br/>DCE & DSW: 01/02/2025 to 30/09/2025 (8 months)

Lot Information

Lot 1 - CM/PHG/23/5697/01 Orals (plus non-parenteral) Products

Potential periods of call-offs under the framework agreement:

CM/PHG/23/5697/01 - Orals (plus non-parenteral) Products:
All Regions (CESW/LSNE/NWLN): 01/02/2025 to 31/05/2027 (28 Months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Lot 2 - CM/PHG/23/5697/02 Hospital Only Products

Potential periods of call-offs under the framework agreement:

CM/PHG/23/5697/02 - Hospital Only Products:
DNW & DLN: 01/02/2025 to 31/01/2027 (24 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Lot 3 - CM/PHG/23/5697/03 Hospital Only Products (Housekeeping)

Potential periods of call-offs under the framework agreement:

CM/PHG/23/5697/03 - Hospital Only Products (Housekeeping):
DLS & DNE: 01/02/2025 to 31/05/2026 (16 months)
DCE & DSW: 01/02/2025 to 30/09/2025 (8 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-046a2f
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/040795-2024
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£806,991,470 £100M-£1B
Lots Value
£806,991,471 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
18 Dec 20241 years ago
Submission Deadline
8 Aug 2024Expired
Future Notice Date
28 Jun 2024Expired
Award Date
5 Nov 20241 years ago
Contract Period
1 Feb 2025 - 31 May 2026 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
114
Supplier Names

AFT Pharma UK

AGB Pharma

AOP Orphan Ltd

Abbvie Ltd

Accord-UK Ltd

Aguettant Ltd

Alturix

Amarox Limited

Arcadia Pharma Ltd T/A Arcadia Medical

Aristo Pharma Limited

Ascend Laboratories UK Ltd

Aspen Pharmacare UK Limited

Aspire Pharma Limited

Aventis Pharma ltd t/a Sanofi

B. Braun Medical Limited

Bausch + Lomb (Pharma)

Baxter Healthcare Ltd

Beaumont Pharma Ltd

Biocon

Bowmed Ibisqus Limited

Brown and Burk UK Ltd

CST Pharma Limited

Celix Pharma Ltd.

Chiesi Limited

Cipla

Colonis Pharma Ltd

Consilient Health Ltd

Correvio GmbH

Crescent Pharma Ltd

Day Lewis Medical Ltd

Desitin Pharma Ltd

Dr.Reddy's Laboratories (UK) Limited

Drugsrus Ltd

Eramol (UK) Ltd

Esteve Pharmaceuticals Ltd

Evolan Pharma

FLYNN PHARMA LTD

Farmak Pharmaceuticals

Ferring Pharmaceuticals Ltd

Flexipharm Austrading Limited

Focus Pharmaceuticals Ltd

Fontus Health Ltd

Fresenius Kabi Limited

G.L. Pharma UK Limited

GENNISIUM PHARMA

Galvany Pharma Ltd

GlaxoSmithKline UK Limited

Glenmark Pharmaceuticals Europe Limited

Grindeks Kalceks UK Ltd

Grunenthal

Hikma Pharmaceuticals

Immedica Pharma AB

Kent Pharma Ltd

Lipomed AG

LogixX Pharma Ltd

Lucane Pharma

Lundbeck Limited

MMEU Limited

MSN Laboratories Europe Limited

Macleods Pharma UK Limited

Macure Pharma ApS

Manx Healthcare Ltd

Martindale Pharma

Medreich PLC

Merck Sharpe and Dohme (UK) Limited

Mercury Pharmaceuticals Limited

Milpharm Ltd/aurobinbdo Primary

Morningside Pharmaeuticals

Necessity Supplies Limited

Neuraxpharm UK Ltd

Novartis Pharmaceuticals UK Ltd

Novumgen Limited

Orion Pharma (UK) Ltd

Otsuka Pharmaceuticals UK Limited

Panpharma UK Limited

Pari Medical UK

Perennial Pharma Ltd

Pfizer Ltd

Phoenix Lab

Pierre Fabre Ltd

Piramal Critical care Limited

ROVI Biotech Ltd

RPH Pharmaceuticals AB

Recordati Pharmaceuticals Ltd

Reig Jofre UK limited

Rivopharm UK Ltd

Roma Pharmaceuticals Limited

Rosemont Pharmaceuticals Limited

SVP Pharma Ltd

Sandoz Ltd

Scope Ophthalmics

Seacross Pharmaceuticals Ltd

Selective Supplies Ltd.

Sobi (Swedish Orphan Biovitrum Ltd)

Stirling Anglian Pharmaceuticals Ltd

Strides Pharma Uk LTD

Sun Pharma UK Ltd

Synchrony

Takeda UK Ltd

Tetris Pharma Lts

Teva UK Limited

Thea Pharmaceuticals Limited

Thornton and Ross Ltd

Tillomed Laboratories ltd

Torbay Pharmaceuticals

Torrent Pharma UK Ltd

Vantage Pharmaceuticals Ltd

Viatris UK Healthcare Limited

Waymade PLC

Wockhardt UK Limited

Zentiva Pharma UK Ltd

ennogen healthcare ltd

hameln pharma ltd

medac Pharma LLP

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...